Humanprototype Spółka z Ograniczoną Odpowiedzialnością (KRS 0000505718, NIP 7162815339) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. HUMANPROTOTYPE operates in: Manufacture of other plastic products (PKD 22.29.Z). Industry: Rubber and plastic manufacturing. The company has been listed in the National Court Register since April 10, 2014. HUMANPROTOTYPE's most recently reported net revenue was 0 PLN for 2022.
Historical suspension of activities
Suspension: March 31, 2022 - resumed: June 2, 2025
Negative equity
Negative equity in 5 of 5 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Humanprototype
Identity
- Name
- Humanprototype Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- April 10, 2014
- Registry status as of
- November 20, 2025
- Latest entry
- June 3, 2025
- Founding act
- AKT NOTARIALNY Z DNIA 29.03.2019 R., REPERTORIUM A NUMER 1714/2019, NOTARIUSZ ANNA OSMAN-SOREK, KANCELARIA NOTARIALNA W …
Articles of association history (2)
- 09-04-2014 R.
- March 29, 2019: AKT NOTARIALNY Z DNIA 29.03.2019 R., REPERTORIUM A NUMER 1714/2019, NOTARIUSZ ANNA OSMAN-SOREK, KANCELARIA NOTARIALNA W ŁODZI, ZMIENIONO § 3 UMOWY SPÓŁKI.
Activities
Main activity
22.29.ZManufacture of other plastic products
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. GLINIANA, 19, 91-336, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 51.7768, 19.4547approx.
Risk and payment profile - Humanprototype
Credibility rating
7 / 100
Very poor credibility
Insolvency risk
Very high
Significant formal threat
Closure risk
61
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/12 yrs
Board changes
0
0/12 yrs
PKD changes
1
1/12 yrs
Name changes
0
0/12 yrs
Data from 12 years of registry activity.
Credibility history
Payment reliability score from 2018–2022
Current: E (7/100)
Trend: stable (0.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2022
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Humanprototype
Founded
April 10, 2014
12 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
22.29.Z
Manufacture of other plastic products
Share capital
10.0 K PLN
99 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
5 years
2018–2022 · profitable: 0/5
Registry entries
31
latest: June 3, 2025
Risk signals
Revenue
0 PLN
2022
Net profit
-953.04 PLN
2022
Assets
36.8 K PLN
2022
Equity
-200.0 K PLN
2022
EBITDA
-953.04 PLN
2022
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Humanprototype.
No ratings
Related articles
News
Decora 2026: PLN 648.9 m of revenue (+11.7% YoY), PLN 75 m of net profit and a PLN 42.1 m dividend recommendation (PLN 4.06 per share)
Środa Wielkopolska - Decora S.A. (KRS 0000224559), a Wielkopolska-based producer of flooring underlays, baseboards, finishing profiles, blinds and curtain rods, closed 2025 with revenue of PLN 648.9 m (+11.7% YoY), net profit of PLN 75 m (-0.7%) and EBITDA of PLN 116.8 m (+1.9%). Gross margin rose to around 40.1%. The board recommends a PLN 42.1 m dividend - PLN 4.00 or PLN 4.06 per share (depending on the treasury-share decision) - matching the 2024 level (PLN 4.00). EPS PLN 7.14, share price PLN 74.10 on 30 April 2026, and operating cash flow jumped to PLN 99.95 m (from PLN 63.7 m a year earlier).
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.